Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Cohort Study Evaluating Impact of Hemodialysis on Glycemia: BLOSSOM (Blood Sugar Sensing on Maintenance Dialysis) Cohort Findings.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

The Use of Prophylactic Insulin in Surgical Patients without Diabetes: A Pilot Randomized, Controlled Trial.

Annals of surgery·2026
Same author

Corrigendum to "American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update" [Endocrine Practice. 2026;32(4):473-518].

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use.

Diabetes technology & therapeutics·2026
Same author

Letter: Treatment of Type 2 Diabetes in the United States: 2025.

Diabetes technology & therapeutics·2026
Same author

Glycemic Trends From Continuous Glucose Monitoring With DPP-4 Inhibitor Therapy in Patients With Type 2 Diabetes-Redefining the Role of an Overlooked Agent.

Diabetes care·2026
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
See all related articles

Related Experiment Videos

Web-based collaborative care for type 2 diabetes: a pilot randomized trial.

James D Ralston1, Irl B Hirsch, James Hoath

  • 1Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA. ralston.j@ghc.org

Diabetes Care
|November 20, 2008
PubMed
Summary
This summary is machine-generated.

Web-based care management improved glycemic control in adults with type 2 diabetes. Patients using the online system showed better hemoglobin A1c (GHb) levels compared to those receiving usual care.

Related Experiment Videos

Area of Science:

  • Diabetes management
  • Digital health interventions
  • Clinical informatics

Background:

  • Type 2 diabetes requires ongoing management to control glycemic levels.
  • Traditional care models may not fully engage patients in self-management.
  • Web-based tools offer potential for enhanced patient-provider communication and data monitoring.

Purpose of the Study:

  • To evaluate the effectiveness of Web-based care management for improving glycemic control in patients with type 2 diabetes.
  • To assess the impact of a shared electronic medical record system integrated with patient communication tools.

Main Methods:

  • A randomized trial involving 83 adults with type 2 diabetes and elevated GHb levels (>=7.0%).
  • Intervention group received 12 months of Web-based care management including EHR access, secure messaging, and a digital diary.
  • Control group received usual care. Patients had home Web access and used English-based programs.

Main Results:

  • A significant average decline of 0.7% in GHb levels was observed in the intervention group compared to the usual care group.
  • No significant differences were found in systolic or diastolic blood pressure, or total cholesterol levels between groups.
  • Use of in-person healthcare services also did not differ between the intervention and control groups.

Conclusions:

  • Secure Web-based patient-provider communications effectively improved glycemic control in individuals with type 2 diabetes.
  • Digital health platforms can be a valuable tool in managing chronic conditions like diabetes.
  • Further research can explore long-term effects and broader implementation strategies.